))
Synchron buys equity stake in Acquandas; Zeiss, Topcon settle trade secret theft suit
Manage episode 398843270 series 3481361
Contenuto fornito da Fast Five by MassDevice. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Fast Five by MassDevice o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 2, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. BD is increasing its revenue guidance after releasing its Q1 earnings results. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the earnings results and how BD's medical segment performed. Cortex initiated a trial of its mapping technology for atrial fibrillation ablation. Hear more about the trial and company's technology. SoniVie has completed enrollment in a trial of its ultrasound renal denervation technology for hypertension. Whooley explains how the technology works and how optimistic executives are about completing the trial. Zeiss and Topcon have settled a trade secret theft lawsuit. The Fast Five hosts discuss the terms of the settlement and what Zeiss' original complaint was in the suit. BCI developer Synchron bought an equity stake in thin film maker Acquandas. Find out more about Acquandas' technology and executives' excitement.
…
continue reading
161 episodi
Condividi
